ArticleHealth science reports2026
Clinical Features of Malignant Ovarian Germ Cell Tumors According to Demographic and Pathologic Characteristics.
Article in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: Malignant ovarian germ cell tumors (MOGCTs) are aggressive cancers affecting mainly young women, in whom fertility preservation is important. Diagnosis is often delayed because early symptoms are non-specific, leading to advanced disease or emergency surgery that may limit optimal staging and fertility-sparing treatment. As no effective screening exists and early detection improves survival, increased symptom awareness is essential. This study describes the demographic and clinical characteristics of MOGCTs to support earlier diagnosis. Methods: The present study is a descriptive-analytical cohort study conducted at Vali-ASR Hospital in Tehran, Iran, from 2001 to 2018. Patients with malignant ovarian tumors were evaluated with respect to demographic characteristics, obstetric and medical history, pathological findings, and clinical signs and symptoms before and at the time of diagnosis. The duration of symptoms was also recorded. Data was analyzed using SPSS version 24, employing descriptive statistical methods. Results: The mean age of MOGCT cases (128 ones) was 23.88 ± 7.85 years. We found abdominal distension (45%) followed by acute pain (40.95%), chronic pain (23.95%), menstrual irregularity (14.7%), sense of abdominal firmness and mass (7.72%), nausea (5.4%), fever (5.4%), lack of apatite (4.63%), virilization (3.1%), and depletion of weight (3.1%). Abdominal distension and pain, acute or chronic, and menstrual disorders were the most common symptoms in all patients, but their incidence declined along with aging. The percentage of abdominal distention, ascites, and menstrual disorders in parous women was less than that of nullipara. Conclusion: MOGCTs present a significant diagnostic challenge due to their nonspecific and often misinterpreted symptoms, which vary notably by histologic subtype. Our findings emphasize that a high index of suspicion, coupled with an understanding of this symptom variability, is crucial for the timely diagnosis and improved management of these aggressive tumors, particularly in young women.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.